Patent Drawings: Navigating the Evolving Global Colored Drawing Requirements Landscape

Mr. Balis advises on several areas of local and international intellectual property and specializes in mechanical and aerospace technology. He acts for a wide variety of clients, including multinationals, small-medium enterprises and sole traders. Mr. Balis has previously acted for one of the world’s largest aerospace companies. He brings with him a wealth of experience in prosecuting patent applications in several industries and technology areas. These include: aerospace, automotive, vapour compression systems, mining, medical and consumer products. Mr. Balis also has valuable experience in drafting patent applications, providing infringement opinions and clearance advice across various industries. He also has experience in preparing and prosecuting design applications in Australia and internationally, design infringement and validity analysis, and design freedom to operate analysis.

For over 20 years, Ms. Enmon has been representing clients as a patent attorney in the Chemistry, Biotech and Life Science fields. Having gained experience as both external and in-house counsel, she understands the needs of clients and provides commercially relevant advice. Ms. Enmon is both scientifically and legally trained. She is uniquely qualified having earned registration as a patent attorney in Australia, New Zealand, Europe and the United States. Ms. Enmon is also qualified to practice law before the U.S. courts in California and New York. Her technical expertise encompasses small molecule and large biomolecule therapeutics, gene and cell therapeutics, medical nutrition, molecular biology and organic chemistry. Ms. Enmon's practice has focused on guiding clients in successful protection of their inventions with a unique global perspective as well as advising on validity, infringement, inventorship and freedom-to-operate analyses of Australian, US and European patents.

Ms. Lund primarily advises clients within the chemical and biochemical areas, with specific focus on food, medical device chemistry and biomarkers. She has worked with patents since 2001 when she started her career within this area as an Examiner at the Danish Patent and Trademark Office. Prior to joining Guardian IP Consulting, Ms. Lund has worked as a Patent Manager in the Industry in a medical device company as well as at a multinational food ingredient company. She has extensive experience with novelty searches and patentability evaluations; patentability opinions, drafting patent applications and patent prosecution; evaluating and ensuring clients’ FTO in their markets in respect of competitors’ patent rights by means of FTO-analyses, infringement assessments, third party observations, oppositions etc.; and integration of intellectual property rights in the business strategies of the clients and their practical implementation.

For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology, and chemistry sectors. She brings in-depth knowledge and extensive experience to her work, advising clients on the global patent protection, freedom to operate, and validity of blockbuster drugs they aim to produce and distribute. With a background in chemistry and biology, Ms. Mueller provides advice on the full spectrum of global intellectual property portfolio management, including patent prosecution, opposition, and other post-grant proceedings, and diverse regulatory matters. Since 2001, she has worked closely with in-house legal departments of global pharmaceutical firms regarding their patent development and enforcement strategies. In this partnership, Ms. Mueller provides training to new in-house counsel. She meets with scientists and other business development to anticipate and resolve a wide array of problems, including navigation of FDA approval. A thought leader on pharmaceutical and biopharmaceutical patent law, Ms. Mueller frequently speaks to legal and industry groups and publishes widely.

Mr. Sioufi works alongside a team of technical experts with various technical backgrounds and provides technical and legal support across to all Saba IP branch offices. Mr. Sioufi and his team manage several key patent portfolios from pre-filing recommendations and strategy through prosecution and grant. He attends IP conferences on a regular basis and has presented on a number of those such as AIPLA, BIO and GPCA. Mr. Sioufi is the author on a number of patent-related articles on the MENA region published on blogs, the firm website, MIP, and The Patent Lawyer. Before joining Saba IP, Mr. Sioufi worked in the pharmaceuticals industry. He occupied various roles of increasing responsibility in R&D and later on the corporate side as Alliance Manager where he managed portfolios with Genzyme (now Sanofi), Eli Lilly, Abbott and others. During his tenure at Ionis Pharmaceuticals in San Diego, CA, he co-authored several articles published in peer-reviewed scientific journals and was a co-inventor on several patents. Mr. Sioufi’s technical background includes pharmaceuticals, RNAs, protein binding, PK/PD and various therapeutic areas including cardiovascular, oncology, inflammatory and neurodegenerative, as well as rare diseases.

Ms. Sørensen has extensive experience and up-to-date knowledge in the field of biotechnology based on a nine-year international research career, primarily in the areas of enzyme technology, microbial cell factories, molecular biology, microbiology, biochemistry, biofuels and renewable energies industry. With a strong scientific background, she directed her career towards the field of IPR in 2016. In view of her research career and hands-on experience, Ms. Sørensen understands the challenges in biotechnology and is able to view an invention from the inventors’ perspective. This, combined with her patent consulting experience, is the foundation in how she provides excellent advice and services to clients in relation to patentability opinions, patent application drafting, and patent prosecution. Ms. Sørensen has experience in identifying and protecting inventions that bring value to the patent owner, investigating and securing the client’s FTO in their commercial markets; as well as overall integration of IPR into start-up companies’ business strategy. Furthermore, she also has experience in opposition proceedings at the EPO as well as litigation work in the Danish courts.